Keryx Biopharm Inc (KERX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2007 | 12-2006 | 12-2005 | 12-2004 | 12-2003 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -90,062 | -73,764 | -26,895 | -32,943 | -9,108 |
| Depreciation Amortization | 130 | 176 | 190 | 155 | 940 |
| Income taxes - deferred | N/A | N/A | N/A | N/A | 102 |
| Other Working Capital | 21,210 | 6,818 | -417 | 487 | -1,511 |
| Other Operating Activity | 11,177 | 14,569 | 1,371 | 20,297 | 2,283 |
| Operating Cash Flow | $-57,545 | $-52,201 | $-25,751 | $-12,004 | $-7,294 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 37,384 | -27,455 | 8,898 | -10,404 | 944 |
| PPE Investments | -3,159 | -7,582 | -963 | -24 | 384 |
| Purchase Of Investment | -6,372 | -16,677 | -21,270 | N/A | N/A |
| Sale Of Investment | 3 | 5 | 185 | N/A | 416 |
| Other Investing Activity | 15 | -219 | -23 | -12 | -417 |
| Investing Cash Flow | $27,871 | $-51,928 | $-13,173 | $-10,440 | $1,327 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | N/A | N/A | N/A | -6,322 | N/A |
| Common Stock Issued | 271 | 84,685 | 77,400 | 36,696 | 14,314 |
| Common Stock Repurchased | -268 | N/A | N/A | N/A | -12 |
| Financing Cash Flow | $3 | $84,685 | $77,400 | $30,374 | $14,302 |
| Exchange Rate Effect | N/A | N/A | N/A | 3 | -13 |
| Beginning Cash Position | 48,736 | 68,175 | 29,699 | 21,672 | 13,350 |
| End Cash Position | 19,065 | 48,736 | 68,175 | 29,699 | 21,672 |
| Net Cash Flow | $-29,671 | $-19,439 | $38,476 | $8,027 | $8,322 |
| Free Cash Flow | |||||
| Operating Cash Flow | -57,545 | -52,201 | -25,751 | -12,004 | -7,294 |
| Capital Expenditure | -3,159 | -7,582 | -964 | -24 | -3 |
| Free Cash Flow | -60,704 | -59,783 | -26,715 | -12,028 | -7,297 |